Trials / Completed
CompletedNCT01745380
Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults
A Phase 3, Multi-Center, Randomized, Double-Blind, Parallel-Groups Clinical Trial Comparing the Efficacy and Safety of Intranasally Administered Kovacaine Mist to Placebo for Anesthetizing Maxillary Teeth in Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- St. Renatus, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of Kovacaine Mist, and Placebo for inducing pulpal anesthesia of the maxillary teeth in adults.
Detailed description
The study will employ a multi-center, randomized, double-blind, placebo-controlled, parallel-groups design to assess the safety and efficacy of Kovacaine Mist delivered intranasally for inducing pulpal anesthesia of maxillary teeth numbers 4 to 13 (maxillary right second premolar to maxillary left second premolar) sufficient to allow completion of the Study Dental Procedure. The maxillary teeth will be categorized in two subsets, anteriors (teeth numbers 6 to 11) and premolars (teeth numbers 4, 5, 12 and 13). The intent is to treat 150 subjects at 3 study sites, 2:1 randomization within each study site, and an overall goal of 100 subjects treated with Kovacaine Mist and 50 treated with placebo. Recruitment will be from diverse dental patient populations with at least 25% of subjects over 50 years of age. Randomization will be within strata defined by age (≤50 and \>50 years).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tetracaine HCl 3% and Oxymetazoline HCl 0.05% | The study drug is regional anesthetic delivered intranasally on the same side as the operative tooth |
| DRUG | Placebo | The placebo spray was identical in appearance to and was administered in the same volume and manner as the active ingredient. |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2012-12-10
- Last updated
- 2017-01-31
- Results posted
- 2017-01-31
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01745380. Inclusion in this directory is not an endorsement.